CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
People›
Jay West
AddedMar 31, 2024
UpdatedOct 16, 2026
Jay West

Jay West

Co-Founder, BioSkryb Genomics

Jay West's Career

BioSkryb Genomics

BioSkryb Genomics

Series A$31.5MDurham, NC, US
Co-Founder

Leadership at BioSkryb Genomics

Suresh PisharodySuresh PisharodyCEO
Charles GawadCharles GawadBoard Member
David MichaelDavid MichaelBoard Member

Similar to BioSkryb Genomics

Atrandi BiosciencesAtrandi BiosciencesVilnius, LTest. 2016Atrandi BiosciencesVilnius, LT · est. 2016

Atrandi Biosciences builds instruments and kits for high-throughput single-cell analysis using semi-permeable capsules and droplet microfluidics.

Series A · $25M
Scribe BiosciencesScribe BiosciencesSan Francisco, CA, USBiotechest. 2017Scribe BiosciencesSan Francisco, CA, US · est. 2017

Scribe Biosciences: Pioneering tech for immunotherapy discoveries via single-cell profiling.

Seed · $3.1M7
Singular GenomicsSingular GenomicsSan Diego, CA, USGenomic Technologiesest. 2016Singular GenomicsSan Diego, CA, US · est. 2016

Singular Genomics: A dynamic, fast-paced biotech company in California, innovating in genomic technologies.

Public · $176M134
Spatial GenomicsSpatial GenomicsPasadena, CA, USGenomic Analysisest. 2016Spatial GenomicsPasadena, CA, US · est. 2016

Pioneering spatial analysis and comprehensive single-cell assay in intact cells and tissues.

Series A · $56M24
Arcxis Biotechnologies

Arcxis Biotechnologies

$3.7MPleasanton, CA, US
Co-Founder

Leadership at Arcxis Biotechnologies

Kyle HukariKyle HukariCo-Founder
Christine MedaChristine MedaCEO
John D SteuartJohn D SteuartBoard Member

Similar to Arcxis Biotechnologies

NanopathNanopathCambridge, MA, USDiagnostics, Womens Healthest. 2019NanopathCambridge, MA, US · est. 2019

Nanopath: A molecular diagnostics firm revolutionizing testing for women's health in a single visit.

Series A · $10.3M30
Arc BioArc BioMenlo Park, CA, USDrug Development, Research Toolsest. 2016Arc BioMenlo Park, CA, US · est. 2016

Arc Bio LLC: Innovating in life sciences, engineering, and physical research for drug development.

$1.9M31
HTG Molecular DiagnosticsHTG Molecular DiagnosticsTucson, AZ, USBiomarker Development, Molecular Profilingest. 1997HTG Molecular DiagnosticsTucson, AZ, US · est. 1997

HTG Molecular Diagnostics, Inc. develops and markets technology for complex molecular profiling and biomarker development.

Public · $106.5M107
Molecular BiometricsMolecular BiometricsNorwood, MA, USHealth Diagnosticsest. 2005Molecular BiometricsNorwood, MA, US · est. 2005

Molecular Biometrics develops non-invasive methods using metabolomic technologies for health evaluation.

Series B · $24.5M30

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

People Similar to Jay West

Carlos BustamanteCarlos BustamanteCo-Founder · Arc BioSaeid AkhtariSaeid AkhtariFounder · HBM GenomicsPeter WagnerPeter WagnerFounder · ZyomyxCaroline LandauCaroline LandauCo-Founder · PreDxion BioMike AicherMike AicherBoard Member · Roswell Biotechnologies